Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Gasparini

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Synapse (New York, N.Y.)|August 8, 2014
Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [<sup>11</sup> C]ABP688 PET imagingWilliam B Mathews, Hiroto Kuwabara, Kirstie Stansfield, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5Simon M Ametamey, Lea J Kessler, Michael Honer, et al.
Bioorganic & Medicinal Chemistry|November 18, 2006
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studiesSamuel Hintermann, Ivo Vranesic, Hans Allgeier, et al.
Neuroimage|February 27, 2007
Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillatorMatthias T Wyss, Simon M Ametamey, Valerie Treyer, et al.
Plos Pathogens|November 28, 2017
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicityDespoina Goniotaki, Asvin K K Lakkaraju, Amulya N Shrivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688Simon M Ametamey, Valerie Treyer, Johannes Streffer, et al.
Advances in Therapy|January 4, 2017
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 StudyDaniel Rutrick, Dan J Stein, Ganesan Subramanian, et al.
Psychopharmacology|December 21, 2012
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/MavoglurantAndreea S Pop, Josien Levenga, Celine E F de Esch, et al.
Behavioural Brain Research|November 13, 2012
Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout miceIlse Gantois, Andreea S Pop, Celine E F de Esch, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
[(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5Fabrizio Gasparini, Hendrik Andres, Peter Josef Flor, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Synapse (New York, N.Y.)|August 8, 2014
Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [<sup>11</sup> C]ABP688 PET imagingWilliam B Mathews, Hiroto Kuwabara, Kirstie Stansfield, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5Simon M Ametamey, Lea J Kessler, Michael Honer, et al.
Bioorganic & Medicinal Chemistry|November 18, 2006
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studiesSamuel Hintermann, Ivo Vranesic, Hans Allgeier, et al.
Neuroimage|February 27, 2007
Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillatorMatthias T Wyss, Simon M Ametamey, Valerie Treyer, et al.
Plos Pathogens|November 28, 2017
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicityDespoina Goniotaki, Asvin K K Lakkaraju, Amulya N Shrivastava, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688Simon M Ametamey, Valerie Treyer, Johannes Streffer, et al.
Advances in Therapy|January 4, 2017
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 StudyDaniel Rutrick, Dan J Stein, Ganesan Subramanian, et al.
Psychopharmacology|December 21, 2012
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/MavoglurantAndreea S Pop, Josien Levenga, Celine E F de Esch, et al.
Behavioural Brain Research|November 13, 2012
Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout miceIlse Gantois, Andreea S Pop, Celine E F de Esch, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
[(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5Fabrizio Gasparini, Hendrik Andres, Peter Josef Flor, et al.
Pageof 7